Trial Profile
A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Valsartan (Primary) ; Hydrochlorothiazide
- Indications Hypertension
- Focus Adverse reactions
- Sponsors Novartis
- 10 Nov 2011 New trial record